Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
34 studies found for:    " May 23, 2012":" June 22, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting HIV Posterior Cheek Enlargement
Condition: HIV Posterior Cheek Enlargement
Intervention: Biological: Botulinum toxin A
22 Completed Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy
Conditions: Male Partner;   HIV Counseling and Testing;   Home Based;   Pregnancy
Intervention: Other: HIV counseling and testing
23 Completed Evaluation of the Bioequivalence of a Combined Formulated Tablet
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
24 Completed Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART
Condition: HIV-1 Infection
Interventions: Drug: Vacc-C5/GM-CSF;   Drug: Vacc-C5/Alhydrogel
25 Terminated Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Lamivudine;   Drug: Tenofovir/Emtricitabine
26 Enrolling by invitation Minority AIDS Initiative Retention and Re-Engagement Project
Condition: HIV/AIDS
Intervention: Behavioral: Enhanced Peer Intervention
27 Recruiting Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya
Condition: Assisted-partner Notification Services
Intervention: Other: Assisted-partner notification services
28 Unknown  Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy
Condition: HiV1- Positive
Intervention: Drug: Abacavir/Lamivudine
29 Recruiting The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Maraviroc (5 days);   Drug: Maraviroc and boceprevir (14 days)
30 Completed Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Condition: AIDS
Intervention: Procedure: Blood sample collection
31 Recruiting Randomized Control Trial on Trauma Focused CBT in Zambia
Conditions: Post Traumatic Stress Disorder;   Depression;   Risk Behaviors
Intervention: Behavioral: Trauma Focused Cognitive Behavioral Therapy
32 Completed Omega-3 Supplementation and Depression Clinical Trial
Condition: Depressive Symptoms
Interventions: Dietary Supplement: Soybean oil soft gels;   Dietary Supplement: Fish oil omega-3 EPA-rich soft gels
33 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Condition: Tuberculosis
Intervention:
34 Completed A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions
Condition: Healthy Participants
Interventions: Drug: darunavir;   Drug: cobicistat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-34) Next Page   
Indicates status has not been verified in more than two years